bf/NASDAQ:VIVO_icon.png

NASDAQ:VIVO

Meridian Bioscience, Inc.

  • Stock

USD

Last Close

33.97

30/01 21:00

Market Cap

1.49B

Beta: -

Volume Today

5.63M

Avg: 686.61K

PE Ratio

−551.87

PFCF: 42.66

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '13
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
revenue
188.69M
-
188.83M
0.08%
194.83M
3.18%
196.08M
0.64%
200.77M
2.39%
213.57M
6.38%
201.01M
5.88%
253.67M
26.19%
317.90M
25.32%
333.02M
4.76%
cost of revenue
67.64M
-
71.59M
5.84%
72.95M
1.90%
68.30M
6.38%
75.94M
11.19%
83.11M
9.44%
82.69M
0.51%
97.42M
17.81%
116.75M
19.84%
144.66M
23.91%
gross profit
121.04M
-
117.24M
3.14%
121.88M
3.96%
127.79M
4.84%
124.83M
2.31%
130.46M
4.51%
118.33M
9.30%
156.25M
32.05%
201.15M
28.74%
188.36M
6.36%
selling and marketing expenses
22.42M
-
24.91M
11.09%
25.60M
2.77%
29.87M
16.68%
32.10M
7.47%
34.47M
7.37%
28.45M
17.47%
26.49M
6.89%
26.78M
1.11%
31.27M
16.78%
general and administrative expenses
30.52M
-
27.39M
10.26%
27.62M
0.83%
30.57M
10.68%
33.04M
8.10%
34.49M
4.38%
34.59M
0.28%
46.42M
34.23%
52.34M
12.75%
57.15M
9.18%
selling general and administrative expenses
52.94M
-
52.30M
1.22%
53.22M
1.76%
60.44M
13.57%
65.14M
7.79%
68.96M
5.85%
63.03M
8.59%
72.91M
15.67%
79.12M
8.52%
88.42M
11.75%
research and development expenses
10.79M
-
12.55M
16.36%
12.61M
0.42%
13.81M
9.60%
15.68M
13.50%
16.87M
7.59%
17.95M
6.39%
23.73M
32.21%
23.91M
0.77%
24.34M
1.77%
other expenses
4.60M
-
-350K
107.62%
cost and expenses
131.37M
-
136.44M
3.86%
138.77M
1.71%
142.55M
2.72%
156.76M
9.97%
168.94M
7.77%
163.67M
3.12%
194.06M
18.57%
224.38M
15.62%
257.07M
14.57%
operating expenses
63.73M
-
64.85M
1.76%
65.82M
1.50%
74.25M
12.81%
80.82M
8.85%
85.83M
6.19%
80.98M
5.65%
96.64M
19.34%
107.63M
11.37%
112.41M
4.44%
interest expense
897K
-
1.64M
83.05%
1.52M
7.43%
1.95M
27.96%
2.63M
35.32%
1.88M
28.65%
1.19M
36.69%
ebitda
62.98M
-
57.67M
8.44%
60.28M
4.53%
58.17M
3.51%
46.19M
20.59%
39.82M
13.78%
43.47M
9.15%
75.49M
73.68%
107.61M
42.55%
72.02M
33.08%
operating income
57.31M
-
52.39M
8.59%
56.06M
7.00%
51.38M
8.35%
37.38M
27.24%
31.58M
15.51%
32.70M
3.53%
61.32M
87.54%
93.03M
51.71%
55.51M
40.34%
depreciation and amortization
5.62M
-
5.56M
1.08%
5.22M
6.18%
6.63M
27.00%
8.12M
22.50%
7.92M
2.39%
9.96M
25.74%
13.57M
36.16%
15.29M
12.67%
16.51M
8.01%
total other income expenses net
48K
-
-284K
691.67%
-997K
251.06%
-734K
26.38%
-953K
29.84%
-1.20M
26.34%
-1.14M
5.15%
-2.03M
77.85%
-2.58M
27.18%
-1.19M
53.97%
income before tax
57.36M
-
52.11M
9.16%
55.06M
5.67%
50.64M
8.03%
36.43M
28.07%
30.38M
16.60%
31.56M
3.87%
59.29M
87.89%
90.45M
52.55%
54.32M
39.95%
income tax expense
19.33M
-
17.36M
10.17%
19.52M
12.43%
18.41M
5.68%
14.87M
19.24%
6.53M
56.09%
7.17M
9.86%
13.11M
82.68%
19.04M
45.30%
11.86M
37.73%
net income
38.03M
-
34.74M
8.65%
35.54M
2.29%
32.23M
9.32%
21.56M
33.11%
23.85M
10.63%
24.38M
2.23%
46.19M
89.43%
71.41M
54.61%
42.46M
40.54%
weighted average shs out
41.23M
-
41.45M
0.56%
41.66M
0.49%
42.01M
0.84%
42.19M
0.42%
42.75M
1.34%
42.90M
0.34%
43.17M
0.64%
44.01M
1.94%
44.01M
0%
weighted average shs out dil
41.90M
-
41.91M
0.04%
42.01M
0.24%
42.39M
0.91%
42.57M
0.42%
42.75M
0.43%
42.90M
0.34%
43.17M
0.64%
44.01M
1.94%
44.01M
0%
eps
0.92
-
0.84
8.70%
0.85
1.19%
0.77
9.41%
0.51
33.77%
0.56
9.80%
0.57
1.79%
1.07
87.72%
1.62
51.40%
0.96
40.74%
epsdiluted
0.91
-
0.83
8.79%
0.85
2.41%
0.76
10.59%
0.51
32.89%
0.56
9.80%
0.57
1.79%
1.07
87.72%
1.62
51.40%
0.96
40.74%

All numbers in USD (except ratios and percentages)